Freed has launched Clinical Evidence, a new feature that provides patient-specific clinical answers during medical visits. The feature gives clinicians answers grounded in published medical literature and linked to trusted sources. Freed Clinical Evidence comes with every Freed plan at no additional cost. Freed, the AI scribe trusted by more than 26,000 clinicians and institutions, announced the new offering. The company serves providers across more than 100 specialties. Clinical Evidence allows providers to ask clinical questions while continuing their existing workflow. It then returns answers supported by published medical evidence and relevant citations.
The feature also uses the patient’s clinical context to sharpen each response. Furthermore, every answer remains completely free from advertising and sponsored content. Each response draws from more than 50 trusted medical sources. These sources include peer-reviewed journals and federal clinical guidance. Clinicians can also open the linked sources and review the original material directly.
Addressing Unanswered Clinical Questions
Freed first launched its AI scribe in 2023. The technology helped clinicians reduce after-hours charting and regain valuable personal time. Since then, Freed has expanded its platform across several parts of the clinical workflow. The company added coding, visit preparation, clinical letters, and an AI-supported front desk. Now, Clinical Evidence extends that workflow further. Instead of only capturing what happened during a visit, Freed can now support clinicians during care delivery.
Research shows that clinicians frequently encounter unanswered clinical questions. Clinicians raise roughly one clinical question for every two patients they see. However, they pursue only about half of those questions. A systematic review examined 72 studies published in JAMA Internal Medicine. The research pooled 7,012 questions raised by clinicians after patient visits. When clinicians searched for answers, they found useful information 78% of the time.
However, the remaining questions often remained unanswered. The review identified limited time as one major barrier. Clinicians also questioned whether useful answers were available. Moreover, the researchers found that this pattern remained stable for decades. The availability of additional online evidence resources did not eliminate the problem. Switching between browser tabs and separate applications can consume valuable clinical time. Therefore, Freed designed Clinical Evidence to work within the existing clinical workflow.
Clinical Evidence Works Inside the Clinical Workflow
Clinical Evidence appears directly in the sidebar of the note that clinicians already use. As a result, providers do not need to open another application or create a separate search. The existing visit and note context helps refine the answers. For example, a pediatrician can ask about weight-based dosing. The resulting answer can account for the patient’s documented weight. Similarly, a psychiatrist can ask about a tapering approach. Clinical Evidence can use information already documented in the patient’s record.
This approach removes several unnecessary workflow steps. Clinicians do not need to open another tab or retype the patient’s case. They also do not need to copy information back into the clinical note. Every response includes linked citations. Freed does not publish the evidence itself. The platform also does not search the open web for clinical answers.
Instead, Clinical Evidence uses a defined collection of more than 50 trusted sources . Some of them are PubMed, Cochrane, FDA, CDC, NIH and NEJM. It is up to clinicians in practice to decide which sources are in the scope of the platform. They also assess the answers produced by the system. Freed’s HIPAA boundary keeps patient information. Furthermore, before any external query is sent by the system, identifying information is removed. Clinical Evidence offers clinical guidelines, recommendations and research to support clinical decision-making. It is not involved in clinical decision making. It also does not offer any treatment guidance to patients.
Freed Keeps Clinical Evidence Free From Advertising
Increased importance of advertising in point-of-care healthcare environments. “In recent years, pharmaceutical companies have increased investment in this space. Point-of-care pharmaceutical marketing spend increased 171% from 2019 to 2023. For the first time in 2024 spending topped $1 billion, according to the Point of Care Marketing Association.
Some of these clinical reference platforms are still free to use because they are ad-supported to help pay for their services. Freed has taken a different route with Clinical Evidence. The company confirmed there are no advertisements in Clinical Evidence. It also doesn’t have a paid placement. The concept is to keep clinical information from commercial influence. Therefore, clinicians can look at the answers without wondering who paid for the information.
“Clinicians shouldn’t have to wonder who paid for the answer on their screen, and they shouldn’t have to accept a generic answer for a specific patient,” said Erez Druk, co-founder and CEO of Freed. “We built this the way a clinician would build it. Real sources, chosen by people who see patients, with the citation right there so you can check our work. The answer belongs to the clinician, not to whoever bought the space.“
With Clinical Evidence, Freed continues expanding its healthcare AI platform. The company now combines clinical documentation with evidence access inside one workflow. As a result, clinicians can access patient-specific clinical information without leaving their existing notes. The feature also keeps source citations available for direct review.
Ultimately, Freed aims to make evidence-based care easier to access during patient visits. Clinical Evidence brings medical literature closer to the point of care. It also supports clinicians while keeping advertising outside the clinical answer.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
